CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Latest close $234.12 as of Aug 4, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 8 parsed filing(s) · 5 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Mar 31, 2026 observed May 6, 2026 filed · 36d Initial Schedule 13G | Initial Schedule 13G | 3.5K | 12.00% | $172.50 | $181.73 | $234.12 |
| Invesco CIK0000914208 | Mar 31, 2026 observed May 6, 2026 filed · 36d Schedule 13G amendment | Reported reduction | 2.4M -298.9K | 12.00% 0.00 pts | $172.50 | $181.73 | $234.12 |
| Invesco CIK0000914208 | Dec 31, 2025 observed Feb 12, 2026 filed · 43d Initial Schedule 13G | Initial Schedule 13G | 2.7M | 12.00% | $199.48 | $158.74 | $234.12 |